Table.

Laboratory Data on Admission.

Blood count					Biochemistry					Coagulation
WBC		2,600	/μL		TP		7	g/dL		PT-INR		1.07
Neut		58	%		Alb		3.5	g/dL		APTT		46	s
Eos		0	%		T-Bil		0.9	mg/dL		Fbg		525	mg/dL
Lymph		28	%		AST		22	U/L		FDP		114.2	μg/mL
Mono		10	%		ALT		18	U/L		D-dimer		60.7	μg/mL
Myelo		3	%		LDH		1,240	U/L
Blast		1	%		Ferritin		6,530	ng/mL		PLG		107	%
Hb		13.6	g/dL		ALP		1,094	U/L		α2-PI		113	%
Plt		72,000	/μL		γ-GTP		36	U/L		PIC		2.7	μg/mL
					BUN		21	mg/dL		TAT		24.9	ng/mL
					UA		5.8	mg/dL		AT-3		107	%
					Cre		0.64	mg/dL
					Na		135	mmol/L		WT-1 mRNA		3,100	copies/μgRNA
					K		3.8	mmol/L		JAK2 V617F mutation		Negative
					Cl		93	mmol/L
					CRP		24.75	mg/dL

WBC: white blood cell, Neut: neutrophils, Eos: eosinophils, Mono: monocytes, Myelo: myelocytes, Hb: hemoglobin, Plt: platelet, TP: total protein, Alb: albumin, T-Bil: total bilirubin, AST: aspartate aminotransferase, ALT: alanine aminotransferase, LDH: lactate dehydrogenase, ALP: alkaline phosphatase, γ-GTP: γ-glutamyl transpeptidase, BUN: blood urea nitrogen, UA: uric acid, Cre: creatinine, Na: natrium, K: potassium, Cl: chlorine, CRP: C-reactive protein, PT-INR: prothrombin time-international normalized ratio, APTT: activated partial thromboplastin time, Fbg: fibrinogen, FDP: fibrin/fibrinogen degradation products, PLG: plasminogen, α2-PI: alpha-2 plasmin inhibitor, PIC: plasmin-α2 plasmin inhibitor complex, TAT: thrombin・antithrombin III complex, AT-3: antithrombin III, WT-1 mRNA: Wilm’s tumor 1 mRNA, JAK2 V617F mutation: Janus kinase 2 V617F mutation